Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 250727, 10 pages
http://dx.doi.org/10.1155/2014/250727
Research Article

Synchronous and Metachronous Breast Malignancies: A Cross-Sectional Retrospective Study and Review of the Literature

1Clinic of Obstetrics and Gynecology, University of Udine, 33100 Udine, Italy
2Department of Surgery, AOU “SM della Misericordia,” 33100 Udine, Italy
3Department of Pathology, AOU “SM della Misericordia,” 33100 Udine, Italy

Received 3 November 2013; Accepted 22 February 2014; Published 27 April 2014

Academic Editor: Hirotaka Iwase

Copyright © 2014 Ambrogio P. Londero et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Hartman, K. Czene, M. Reilly et al., “Incidence and prognosis of synchronous and metachronous bilateral breast cancer,” Journal of Clinical Oncology, vol. 25, no. 27, pp. 4210–4216, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. J. L. Bernstein, R. Lapinski, C. Lynch, T. Holford, and W. D. Thompson, “Factors influencing mortality among young women with second primary breast carcinoma,” Cancer, vol. 95, no. 10, pp. 2051–2058, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. Y. Chen, W. Thompson, R. Semenciw, and Y. Mao, “Epidemiology of contralateral breast cancer,” Cancer Epidemiology Biomarkers and Prevention, vol. 8, no. 10, pp. 855–861, 1999. View at Google Scholar · View at Scopus
  4. M. A. Chaudary, R. R. Millis, E. O. Hoskins et al., “Bilateral primary breast cancer: a prospective study of disease incidence,” The British Journal of Surgery, vol. 71, no. 9, pp. 711–714, 1984. View at Google Scholar · View at Scopus
  5. W. Lu, M. Schaapveld, L. Jansen et al., “The value of surveillance mammography of the contralateral breast in patients with a history of breast cancer,” European Journal of Cancer, vol. 45, no. 17, pp. 3000–3007, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. I. Soerjomataram, W. J. Louwman, V. E. P. P. Lemmens, E. de Vries, W. J. Klokman, and J. W. W. Coebergh, “Risks of second primary breast and urogenital cancer following female breast cancer in the south of The Netherlands, 1972–2001,” European Journal of Cancer, vol. 41, no. 15, pp. 2331–2337, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. H. D. Vuoto, A. M. García, G. B. Candás et al., “Bilateral breast carcinoma: clinical characteristics and its impact on survival,” Breast Journal, vol. 16, no. 6, pp. 625–632, 2010. View at Publisher · View at Google Scholar
  8. M. M. A. Tilanus-Linthorst, K. C. M. Bartels, C. Alves et al., “Selection bias influences reported contralateral breast cancer incidence and survival in high risk non-BRCA1/2 patients,” Breast Cancer Research and Treatment, vol. 95, no. 2, pp. 117–123, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. C. E. Hill-Kayser, E. E. R. Harris, W. T. Hwang, and L. J. Solin, “Twenty-year incidence and patterns of contralateral breast cancer after breast conservation treatment with radiation,” International Journal of Radiation Oncology Biology Physics, vol. 66, no. 5, pp. 1313–1319, 2006. View at Publisher · View at Google Scholar
  10. X. Gao, S. G. Fisher, and B. Emami, “Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study,” International Journal of Radiation Oncology Biology Physics, vol. 56, no. 4, pp. 1038–1045, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. R. S. Samant, I. A. Olivotto, J. S. H. Jackson, and D. Mates, “Diagnosis of metachronous contralateral breast cancer,” Breast Journal, vol. 7, no. 6, pp. 405–410, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Broët, A. de la Rochefordière, S. M. Scholl et al., “Contralateral breast cancer: annual incidence and risk parameters,” Journal of Clinical Oncology, vol. 13, no. 7, pp. 1578–1583, 1995. View at Google Scholar · View at Scopus
  13. F. Levi, L. Randimbison, V. Te, and C. La Vecchia, “Prognosis of bilateral synchronous breast cancer in Vaud, Switzerland,” Breast, vol. 12, no. 2, pp. 89–91, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. J. J. Jobsen, J. van der Palen, F. Ong, and J. H. Meerwaldt, “Synchronous, bilateral breast cancer: prognostic value and incidence,” Breast, vol. 12, no. 2, pp. 83–88, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. D. E. Heron, L. T. Komarnicky, T. Hyslop, G. F. Schwartz, and C. M. Mansfield, “Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease,” Cancer, vol. 88, no. 12, pp. 2739–2750, 2000. View at Publisher · View at Google Scholar
  16. M. M. Lee, R. Heimann, C. Powers, R. R. Weichselbaum, and L. M. Chen, “Efficacy of breast conservation therapy in early stage bilateral breast cancer,” Breast Journal, vol. 5, no. 1, pp. 36–41, 1999. View at Publisher · View at Google Scholar · View at Scopus
  17. W. H. Kuo, A. M. F. Yen, P. H. Lee et al., “Cumulative survival in early-onset unilateral and bilateral breast cancer: an analysis of 1907 Taiwanese women,” The British Journal of Cancer, vol. 100, no. 4, pp. 563–570, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. H. M. Verkooijen, V. Chatelain, G. Fioretta et al., “Survival after bilateral breast cancer: results from a population-based study,” Breast Cancer Research and Treatment, vol. 105, no. 3, pp. 347–357, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Takahashi, K. Watanabe, M. Takahashi, K. Taguchi, F. Sasaki, and S. Todo, “The impact of bilateral breast cancer on the prognosis of breast cancer: a comparative study with unilateral breast cancer,” Breast Cancer, vol. 12, no. 3, pp. 196–202, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. “The world health organization histological typing of breast tumors—second edition. The world organization,” The American Journal of Clinical Pathology, vol. 78, no. 6, pp. 806–816, 1982. View at Scopus
  21. P. Rosen and H. Oberman, Tumors of the Mammary Gland: Atlas of Tumor Pathology, 3rd series, AFIP, Washington, DC, USA, 1993.
  22. C. W. Elston and I. O. Ellis, “Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up,” Histopathology, vol. 19, no. 5, pp. 403–410, 1991. View at Google Scholar · View at Scopus
  23. M. K. Parmar, V. Torri, and L. Stewart, “Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints,” Statistics in Medicine, vol. 17, no. 24, pp. 2815–2834, 1998. View at Publisher · View at Google Scholar
  24. D. F. Stroup, J. A. Berlin, S. C. Morton et al., “Meta-analysis of observational studies in epidemiology: a proposal for reporting,” The Journal of the American Medical Association, vol. 283, no. 15, pp. 2008–2012, 2000. View at Google Scholar · View at Scopus
  25. K. R. Beckmann, J. Buckingham, P. Craft et al., “Clinical characteristics and outcomes of bilateral breast cancer in an Australian cohort,” Breast, vol. 20, no. 2, pp. 158–164, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. A. P. Polednak, “Bilateral synchronous breast cancer: a population-based study of characteristics, method of detection, and survival,” Surgery, vol. 133, no. 4, pp. 383–389, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. A. R. Carmichael, S. Bendall, L. Lockerbie, R. Prescott, and T. Bates, “The long-term outcome of synchronous bilateral breast cancer is worse than metachronous or unilateral tumours,” European Journal of Surgical Oncology, vol. 28, no. 4, pp. 388–391, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. A. A. Fracchia and P. I. Borgen, “Bilateral breast cancer,” Seminars in Surgical Oncology, vol. 7, no. 5, pp. 300–305, 1991. View at Google Scholar · View at Scopus
  29. R. A. Pomerantz, T. Murad, and J. R. Hines, “Bilateral breast cancer,” The American Surgeon, vol. 55, no. 7, pp. 441–444, 1989. View at Google Scholar · View at Scopus
  30. J. M. Dixon, T. J. Anderson, D. L. Page, D. Lee, S. W. Duffy, and H. J. Stewart, “Infiltrating lobular carcinoma of the breast: an evaluation of the incidence and consequence of bilateral disease,” The British Journal of Surgery, vol. 70, no. 9, pp. 513–516, 1983. View at Google Scholar · View at Scopus
  31. T. J. Yeatman, G. H. Lyman, S. K. Smith, D. S. Reintgen, A. B. Cantor, and C. E. Cox, “Bilaterality and recurrence rates for lobular breast cancer: considerations for treatment,” Annals of Surgical Oncology, vol. 4, no. 3, pp. 198–202, 1997. View at Google Scholar · View at Scopus
  32. N. D. Bloom, V. Daluvoy, F. Ceccarelli, and G. A. Degenshein, “Bilateral mammary carcinoma. Immunologic implications,” New York State Journal of Medicine, vol. 80, no. 6, pp. 908–910, 1980. View at Google Scholar · View at Scopus
  33. R. Díaz, B. Munárriz, A. Santaballa, L. Palomar, and J. Montalar, “Synchronous and metachronous bilateral breast cancer: a long-term single-institution experience,” Medical Oncology, vol. 29, no. 1, pp. 16–24, 2012. View at Publisher · View at Google Scholar
  34. H. F. Rauschecker, W. Sauerbrei, W. Gatzemeier et al., “Eight-year results of a prospective non-randomised study on therapy of small breast cancer,” European Journal of Cancer, vol. 34, no. 3, pp. 315–323, 1998. View at Publisher · View at Google Scholar · View at Scopus
  35. D. M. Renz, J. Böttcher, P. A. T. Baltzer et al., “The contralateral synchronous breast carcinoma: a comparison of histology, localization, and magnetic resonance imaging characteristics with the primary index cancer,” Breast Cancer Research and Treatment, vol. 120, no. 2, pp. 449–459, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. D. Huo, S. Melkonian, P. J. Rathouz, A. Khramtsov, and O. I. Olopade, “Concordance in histological and biological parameters between first and second primary breast cancers,” Cancer, vol. 117, no. 5, pp. 907–915, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. H. Bu-Ali, M. Solh, A. Kapur, and V. Mittal, “Receptor characteristics of the second tumor in synchronous versus metachronous breast cancer,” The American Surgeon, vol. 74, no. 8, pp. 702–705, 2008. View at Google Scholar · View at Scopus
  38. M. K. Graeser, C. Engel, K. Rhiem et al., “Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers,” Journal of Clinical Oncology, vol. 27, no. 35, pp. 5887–5892, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. E. A. H. Kheirelseid, H. Jumustafa, N. Miller et al., “Bilateral breast cancer: analysis of incidence, outcome, survival and disease characteristics,” Breast Cancer Research and Treatment, vol. 126, no. 1, pp. 131–140, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. B. Majed, A. Dozol, L. Ribassin-Majed, K. Senouci, and B. Asselain, “Increased risk of contralateral breast cancers among overweight and obese women: a time-dependent association,” Breast Cancer Research and Treatment, vol. 126, no. 3, pp. 729–738, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. J. Kollias, P. G. Gill, B. J. Coventry, P. Malycha, B. Chatterton, and G. Farshid, “Clinical and histological factors associated with sentinel node identification in breast cancer,” Australian and New Zealand Journal of Surgery, vol. 70, no. 7, pp. 485–489, 2000. View at Publisher · View at Google Scholar · View at Scopus
  42. M. J. Kim, E. K. Kim, J. Y. Kwak et al., “Sonographic surveillance for the detection of contralateral metachronous breast cancer in an Asian population,” The American Journal of Roentgenology, vol. 192, no. 1, pp. 221–228, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. S. Alkner, P. Bendahl, M. Fernö, J. Manjer, and L. Rydén, “Prediction of outcome after diagnosis of metachronous contralateral breast cancer,” BMC Cancer, vol. 11, article 114, 2011. View at Publisher · View at Google Scholar · View at Scopus